Literature DB >> 15352929

Serum lipids in schizophrenia and other functional psychoses: a general population northern Finland 1966 birth cohort survey.

K Saari1, J Jokelainen, J Veijola, H Koponen, P B Jones, M Savolainen, M-R Järvelin, L Lauren, M Isohanni, S Lindeman.   

Abstract

OBJECTIVE: To compare fasting serum lipid concentrations of subjects with schizophrenia with a comparison group.
METHOD: The study sample consists of 5654 members of the northern Finland 1966 birth cohort who participated in the field study with blood samples after overnight fasting and clinical examination in 1997-98. Total cholesterol (TC), high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides (TG) and glucose were analyzed. Analysis of variance were used for comparing differences in lipids means between diagnostic categories.
RESULTS: Mean fasting TC in subjects with schizophrenia was 20 mg/dl higher than in the comparison group. TC and TG levels in the group of other psychoses resembled the schizophrenia group.
CONCLUSION: Blood lipid levels in subjects with schizophrenia and other functional psychoses were high. As these persons are at special risk for hyperlipidemia their lipid levels should be regularly monitored, and cholesterol lowering diet, as well as medication, should be considered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15352929     DOI: 10.1111/j.1600-0447.2004.00358.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  10 in total

Review 1.  The antecedents of schizophrenia: a review of birth cohort studies.

Authors:  Joy Welham; Matti Isohanni; Peter Jones; John McGrath
Journal:  Schizophr Bull       Date:  2008-07-24       Impact factor: 9.306

2.  Metabolic changes of Japanese schizophrenic patients transferred from hospitalization to outpatients.

Authors:  Yoriyasu Uju; Tetsuto Kanzaki; Yuki Yamasaki; Tadayuki Kondo; Hideki Nanasawa; Yu Takeuchi; Yuta Yanagisawa; Shun Kusanishi; Chieko Nakano; Tetsuro Enomoto; Akahito Sako; Hidekatsu Yanai; Seisuke Mimori; Kazuei Igarashi; Tsuyoshi Takizawa; Tatsuro Hayakawa
Journal:  Glob Health Med       Date:  2020-06-30

3.  Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients.

Authors:  Y J La; C L Wan; H Zhu; Y F Yang; Y S Chen; Y X Pan; G Y Feng; L He
Journal:  J Neural Transm (Vienna)       Date:  2006-12-14       Impact factor: 3.575

Review 4.  Health habits of patients with schizophrenia.

Authors:  Christiane Roick; Anita Fritz-Wieacker; Herbert Matschinger; Dirk Heider; Jana Schindler; Steffi Riedel-Heller; Matthias C Angermeyer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-02-13       Impact factor: 4.519

Review 5.  Twenty Years of Schizophrenia Research in the Northern Finland Birth Cohort 1966: A Systematic Review.

Authors:  Erika Jääskeläinen; Marianne Haapea; Nina Rautio; Pauliina Juola; Matti Penttilä; Tanja Nordström; Ina Rissanen; Anja Husa; Emmi Keskinen; Riikka Marttila; Svetlana Filatova; Tiina-Mari Paaso; Jenni Koivukangas; Kristiina Moilanen; Matti Isohanni; Jouko Miettunen
Journal:  Schizophr Res Treatment       Date:  2015-05-18

Review 6.  Depression and Cardiovascular Disease: The Viewpoint of Platelets.

Authors:  Patrizia Amadio; Marta Zarà; Leonardo Sandrini; Alessandro Ieraci; Silvia Stella Barbieri
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

7.  Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis.

Authors:  Pruntha Kanagasundaram; Jiwon Lee; Femin Prasad; Kenya A Costa-Dookhan; Laurie Hamel; Madeleine Gordon; Gary Remington; Margaret K Hahn; Sri Mahavir Agarwal
Journal:  Front Psychiatry       Date:  2021-03-17       Impact factor: 4.157

Review 8.  Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis.

Authors:  David P J Osborn; Christine A Wright; Gus Levy; Michael B King; Raman Deo; Irwin Nazareth
Journal:  BMC Psychiatry       Date:  2008-09-25       Impact factor: 3.630

9.  Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study.

Authors:  Dag K Solberg; Håvard Bentsen; Helge Refsum; Ole A Andreassen
Journal:  BMC Psychiatry       Date:  2016-08-25       Impact factor: 3.630

Review 10.  Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences.

Authors:  Marco Carli; Shivakumar Kolachalam; Biancamaria Longoni; Anna Pintaudi; Marco Baldini; Stefano Aringhieri; Irene Fasciani; Paolo Annibale; Roberto Maggio; Marco Scarselli
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.